NIA, JPND Announce Effort to Enhance Transatlantic Collaboration on Neurodegenerative Disease Research
Neuron with dendrites and nucleus
The NIA has teamed up with the EU Joint Programme on Neurodegenerative Disease Research (JPND) to improve collaborative science on neurodegenerative diseases. The two funding organizations recently announced the creation of a new effort to connect and support collaborations between researcher working in the field.
In 2017, NIH and JPND issued separate proposals for investigating common mechanisms and pathways in neurodegenerative diseases. Under the new agreement, researchers supported under the JPND call are encouraged to team up with researchers supported under the NIH call, and vice versa. The enhanced collaboration lays the groundwork for proposing joint activities like pilot experiments, data sharing and scientific workshops. The overall aim is to speed knowledge transfer between the trans-Atlantic research teams.
To date, four projects have been supported through NIH's funding opportunity, “PAS17-028 Common Mechanisms and Interactions Among Neurodegenerative Diseases (R01).” JPND supported ten research consortia through their call for “Multinational research projects for Pathway Analysis across Neurodegenerative Diseases.”
“This is a crucial time of expanding global interest and support for neurodegenerative disease research,” said Dr. Eliezer Masliah, director of the NIA’s Division of Neuroscience. “In our connected age, breakthroughs in Alzheimer’s, vascular dementia, Lewy body disease, frontotemporal dementia and other neurological disorders require teamwork, and we look forward to strengthening the scientific connections between talented researchers across the EU and the US.”
What Makes Good Brain Proteins Turn Bad?News
The protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers have zoomed in on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.
T Cells Attack and Kill Dopamine-Producing Cells in Parkinson's diseaseNews
Researchers in Germany discover a potential new target for treating Parkinson's diseaseREAD MORE
Researchers are One Step Closer to Developing Eye Drops to Treat Age-Related Macular DegenerationNews
Scientists at the University of Birmingham are one step closer to developing an eye drop that could revolutionise treatment for age-related macular degeneration (AMD).READ MORE